ID

28339

Beschreibung

Pre-therapeutic Identification of Dihydropyrimidine Dehydrogenase Gene (DPD) Deficiency for Predicting Toxicity to Fluoropyrimidines; ODM derived from: https://clinicaltrials.gov/show/NCT01547923

Link

https://clinicaltrials.gov/show/NCT01547923

Stichworte

Versionen (1)
  1. 05.01.18 05.01.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

5. Januar 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Colorectal Cancer NCT01547923

Englisch

Eligibility Colorectal Cancer NCT01547923

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
colorectal cancer, histologically confirmed, with all types included (including adjuvant cases), requiring treatment with intravenous 5-fluorouracil.
Beschreibung

Colorectal Carcinoma Type All | Adjuvant therapy | 5-Fluorouracil Intravenous Patient need for

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009402
UMLS CUI [1,2]
C0332307
UMLS CUI [1,3]
C0444868
UMLS CUI [2]
C0677850
UMLS CUI [3,1]
C0016360
UMLS CUI [3,2]
C1522726
UMLS CUI [3,3]
C0686904
anterior chemotherapy authorised, with the exception of chemotherapy containing a derivate of 5-fluorouracil
Beschreibung

Prior Chemotherapy | Exception 5-Fluorouracil Derivative

Datentyp

boolean

Alias
UMLS CUI [1]
C1514457
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0016360
UMLS CUI [2,3]
C1527240
age > or = 18 years
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
who performance status < or = 2
Beschreibung

WHO performance status scale

Datentyp

boolean

Alias
UMLS CUI [1]
C1298650
haematologic and hepatic parameters : neutrophils > or = 1000 /mm3, platelets > or = 100000/mm3, total bilirubin < or = 2 x uln, ast and alt < or = 3 x uln, apl < or = 5 x uln
Beschreibung

Hematologic function | Liver function | Neutrophil count | Platelet Count measurement | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Alkaline phosphatase measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0200633
UMLS CUI [4]
C0032181
UMLS CUI [5]
C1278039
UMLS CUI [6]
C0201899
UMLS CUI [7]
C0201836
UMLS CUI [8]
C0201850
complete initial assessment before first treatment administration for imaging and pharmacogenetic, within 15 days for biology, and within 7 days for clinical examination.
Beschreibung

Initial assessment Complete | Therapeutic procedure First Imaging | Therapeutic procedure First Pharmacogenetic Test | Therapeutic procedure First Test biological | Therapeutic procedure First Clinical examination

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0150637
UMLS CUI [1,2]
C0205197
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0205435
UMLS CUI [2,3]
C0011923
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C0205435
UMLS CUI [3,3]
C2347500
UMLS CUI [4,1]
C0087111
UMLS CUI [4,2]
C0205435
UMLS CUI [4,3]
C0039593
UMLS CUI [4,4]
C0205460
UMLS CUI [5,1]
C0087111
UMLS CUI [5,2]
C0205435
UMLS CUI [5,3]
C1456356
signed written informed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior chemotherapy with fluoropyrimidines
Beschreibung

fluoropyrimidine

Datentyp

boolean

Alias
UMLS CUI [1]
C0596581
symptomatic or uncontrolled ventral nervous system metastases
Beschreibung

CNS metastases Symptomatic | CNS metastases Uncontrolled

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0686377
UMLS CUI [1,2]
C0231220
UMLS CUI [2,1]
C0686377
UMLS CUI [2,2]
C0205318
psychiatric disease disrupting the trial understanding and the enlightened and voluntary consent character
Beschreibung

Mental disorder Preventing Comprehension Study Protocol | Mental disorders Preventing Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0004936
UMLS CUI [1,2]
C1292733
UMLS CUI [1,3]
C0162340
UMLS CUI [1,4]
C2348563
UMLS CUI [2,1]
C0004936
UMLS CUI [2,2]
C1292733
UMLS CUI [2,3]
C0021430
patient who is pregnant or breast feeding
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
woman not consenting to use adequate contraceptive precautions during the study
Beschreibung

Gender Contraceptive methods Unwilling

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C0558080
patient who can not submit itself to the formal follow-up for psychological, social, family or geographical reasons
Beschreibung

Follow-up Unsuccessful Due to Psychological Factors | Follow-up Unsuccessful Due to Social factor | Follow-up Unsuccessful Due to Factor Familial | Follow-up Unsuccessful Due to Geographic Factors

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3274571
UMLS CUI [1,2]
C1272705
UMLS CUI [1,3]
C0678226
UMLS CUI [1,4]
C0033898
UMLS CUI [2,1]
C3274571
UMLS CUI [2,2]
C1272705
UMLS CUI [2,3]
C0678226
UMLS CUI [2,4]
C0337460
UMLS CUI [3,1]
C3274571
UMLS CUI [3,2]
C1272705
UMLS CUI [3,3]
C0678226
UMLS CUI [3,4]
C1521761
UMLS CUI [3,5]
C0241888
UMLS CUI [4,1]
C3274571
UMLS CUI [4,2]
C1272705
UMLS CUI [4,3]
C0678226
UMLS CUI [4,4]
C0017444
significant serious pathology or any instable medical condition (cardiac pathology uncontrolled, myocardial infarction within 6 months before enrollment, systemic active uncontrolled infection)
Beschreibung

Pathology Serious | Medical condition Unstable | Heart Disease Uncontrolled | Myocardial Infarction | Sepsis Uncontrolled

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0677042
UMLS CUI [1,2]
C0205404
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0443343
UMLS CUI [3,1]
C0018799
UMLS CUI [3,2]
C0205318
UMLS CUI [4]
C0027051
UMLS CUI [5,1]
C0243026
UMLS CUI [5,2]
C0205318
any investigational agent within 4 weeks before enrollment
Beschreibung

Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Colorectal Cancer NCT01547923

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Colorectal Carcinoma Type All | Adjuvant therapy | 5-Fluorouracil Intravenous Patient need for
Item
colorectal cancer, histologically confirmed, with all types included (including adjuvant cases), requiring treatment with intravenous 5-fluorouracil.
boolean
C0009402 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
C0444868 (UMLS CUI [1,3])
C0677850 (UMLS CUI [2])
C0016360 (UMLS CUI [3,1])
C1522726 (UMLS CUI [3,2])
C0686904 (UMLS CUI [3,3])
Prior Chemotherapy | Exception 5-Fluorouracil Derivative
Item
anterior chemotherapy authorised, with the exception of chemotherapy containing a derivate of 5-fluorouracil
boolean
C1514457 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0016360 (UMLS CUI [2,2])
C1527240 (UMLS CUI [2,3])
Age
Item
age > or = 18 years
boolean
C0001779 (UMLS CUI [1])
WHO performance status scale
Item
who performance status < or = 2
boolean
C1298650 (UMLS CUI [1])
Hematologic function | Liver function | Neutrophil count | Platelet Count measurement | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Alkaline phosphatase measurement
Item
haematologic and hepatic parameters : neutrophils > or = 1000 /mm3, platelets > or = 100000/mm3, total bilirubin < or = 2 x uln, ast and alt < or = 3 x uln, apl < or = 5 x uln
boolean
C0221130 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0200633 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
C1278039 (UMLS CUI [5])
C0201899 (UMLS CUI [6])
C0201836 (UMLS CUI [7])
C0201850 (UMLS CUI [8])
Initial assessment Complete | Therapeutic procedure First Imaging | Therapeutic procedure First Pharmacogenetic Test | Therapeutic procedure First Test biological | Therapeutic procedure First Clinical examination
Item
complete initial assessment before first treatment administration for imaging and pharmacogenetic, within 15 days for biology, and within 7 days for clinical examination.
boolean
C0150637 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0205435 (UMLS CUI [2,2])
C0011923 (UMLS CUI [2,3])
C0087111 (UMLS CUI [3,1])
C0205435 (UMLS CUI [3,2])
C2347500 (UMLS CUI [3,3])
C0087111 (UMLS CUI [4,1])
C0205435 (UMLS CUI [4,2])
C0039593 (UMLS CUI [4,3])
C0205460 (UMLS CUI [4,4])
C0087111 (UMLS CUI [5,1])
C0205435 (UMLS CUI [5,2])
C1456356 (UMLS CUI [5,3])
Informed Consent
Item
signed written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
fluoropyrimidine
Item
prior chemotherapy with fluoropyrimidines
boolean
C0596581 (UMLS CUI [1])
CNS metastases Symptomatic | CNS metastases Uncontrolled
Item
symptomatic or uncontrolled ventral nervous system metastases
boolean
C0686377 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0686377 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Mental disorder Preventing Comprehension Study Protocol | Mental disorders Preventing Informed Consent
Item
psychiatric disease disrupting the trial understanding and the enlightened and voluntary consent character
boolean
C0004936 (UMLS CUI [1,1])
C1292733 (UMLS CUI [1,2])
C0162340 (UMLS CUI [1,3])
C2348563 (UMLS CUI [1,4])
C0004936 (UMLS CUI [2,1])
C1292733 (UMLS CUI [2,2])
C0021430 (UMLS CUI [2,3])
Pregnancy | Breast Feeding
Item
patient who is pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Gender Contraceptive methods Unwilling
Item
woman not consenting to use adequate contraceptive precautions during the study
boolean
C0079399 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
Follow-up Unsuccessful Due to Psychological Factors | Follow-up Unsuccessful Due to Social factor | Follow-up Unsuccessful Due to Factor Familial | Follow-up Unsuccessful Due to Geographic Factors
Item
patient who can not submit itself to the formal follow-up for psychological, social, family or geographical reasons
boolean
C3274571 (UMLS CUI [1,1])
C1272705 (UMLS CUI [1,2])
C0678226 (UMLS CUI [1,3])
C0033898 (UMLS CUI [1,4])
C3274571 (UMLS CUI [2,1])
C1272705 (UMLS CUI [2,2])
C0678226 (UMLS CUI [2,3])
C0337460 (UMLS CUI [2,4])
C3274571 (UMLS CUI [3,1])
C1272705 (UMLS CUI [3,2])
C0678226 (UMLS CUI [3,3])
C1521761 (UMLS CUI [3,4])
C0241888 (UMLS CUI [3,5])
C3274571 (UMLS CUI [4,1])
C1272705 (UMLS CUI [4,2])
C0678226 (UMLS CUI [4,3])
C0017444 (UMLS CUI [4,4])
Pathology Serious | Medical condition Unstable | Heart Disease Uncontrolled | Myocardial Infarction | Sepsis Uncontrolled
Item
significant serious pathology or any instable medical condition (cardiac pathology uncontrolled, myocardial infarction within 6 months before enrollment, systemic active uncontrolled infection)
boolean
C0677042 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
C0018799 (UMLS CUI [3,1])
C0205318 (UMLS CUI [3,2])
C0027051 (UMLS CUI [4])
C0243026 (UMLS CUI [5,1])
C0205318 (UMLS CUI [5,2])
Investigational New Drugs
Item
any investigational agent within 4 weeks before enrollment
boolean
C0013230 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video